113 related articles for article (PubMed ID: 8200721)
1. Action of 2-acetoxy-trifluoromethylbenzoic acid (Triflusal) on platelet function after repeated oral administration in man: a pharmacological clinical study.
Messa GL; Franchi M; Auteri A; Di Perri T
Int J Clin Pharmacol Res; 1993; 13(5):263-73. PubMed ID: 8200721
[TBL] [Abstract][Full Text] [Related]
2. Influence of triflusal on platelet activation after coronary artery bypass graft.
Prieto MA; De La Cruz JP; Del Prado MF; Sánchez de la Cuesta F
Blood Coagul Fibrinolysis; 2000 Mar; 11(2):191-7. PubMed ID: 10759013
[TBL] [Abstract][Full Text] [Related]
3. Effects of triflusal in patients with prosthetic heart valves.
Dominguez MJ; Vacas M; Sáez Y; Olabarría I; Velasco A; Iriarte JA; Forn J
Clin Ther; 1985; 7(3):357-60. PubMed ID: 3838919
[TBL] [Abstract][Full Text] [Related]
4. [Antiaggregant effect and tolerance of calcium carbasalate administrated immediately after aorto-coronary bypass. Results of a double-blind versus placebo study].
Mathieu P; Villemot JP; Stoltz JF; Scheck F; Garnier LF
Pathol Biol (Paris); 1996 Jun; 44(6):571-80. PubMed ID: 8977914
[TBL] [Abstract][Full Text] [Related]
5. Platelet antiaggregatory effect of triflusal in human whole blood.
de la Cruz JP; Pavia J; Bellido I; González MC; Sánchez de la Cuesta F
Methods Find Exp Clin Pharmacol; 1988 Apr; 10(4):273-7. PubMed ID: 3386335
[TBL] [Abstract][Full Text] [Related]
6. Triflusal in the treatment of patients with chronic peripheral arteriopathy: multicentre double-blind clinical study vs placebo.
Auteri A; Angaroni A; Borgatti E; Catalano M; De Vizzi GB; Forconi S; Fossati L; Girardello R; Ambrosoli L; Poli A
Int J Clin Pharmacol Res; 1995; 15(2):57-63. PubMed ID: 8593974
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
8. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.
Renda G; Tacconelli S; Capone ML; Sacchetta D; Santarelli F; Sciulli MG; Zimarino M; Grana M; D'Amelio E; Zurro M; Price TS; Patrono C; De Caterina R; Patrignani P
Clin Pharmacol Ther; 2006 Sep; 80(3):264-74. PubMed ID: 16952493
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of the effect of low-dosage acetylsalicylic acid and triflusal in the prevention of cardiovascular events among young adults with ischemic cerebrovascular disease].
Matías-Guiu J; Alvarez-Sabín J; Codina A
Rev Neurol; 1997 Nov; 25(147):1669-72. PubMed ID: 9484514
[TBL] [Abstract][Full Text] [Related]
10. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus.
Falco A; Salvati F; Vitacolonna E; Avellone G; Pinto A; Di Febbo C; Ballone E; Di Nicola M; Ciabattoni G; Davì G
Atherosclerosis; 2005 Dec; 183(2):329-35. PubMed ID: 16285996
[TBL] [Abstract][Full Text] [Related]
12. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
[TBL] [Abstract][Full Text] [Related]
13. A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers.
Greenberg HE; Gottesdiener K; Huntington M; Wong P; Larson P; Wildonger L; Gillen L; Dorval E; Waldman SA
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1509-15. PubMed ID: 11185674
[TBL] [Abstract][Full Text] [Related]
14. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
[TBL] [Abstract][Full Text] [Related]
15. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
[TBL] [Abstract][Full Text] [Related]
16. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
[TBL] [Abstract][Full Text] [Related]
17. Compliance of geriatric patients subjected to antiplatelet agents with Triflusal in peripheral arteriopathy. Preliminary data.
Zan S; Maselli M; Moniaci D; Varetto G; Ortensio M; Apostolou D; Comelli S; Scovazzi P
Minerva Cardioangiol; 2002 Jun; 50(3):263-70. PubMed ID: 12107407
[TBL] [Abstract][Full Text] [Related]
18. [Effect of chuan-xiong granules on platelet aggregation, plasma beta-thromboglobulin, platelet factor IV, thromboxane B2 and 6-keto-prostaglandin F1 alpha in coronary disease patients].
Yu Z; Chen KJ
Zhong Xi Yi Jie He Za Zhi; 1987 Jan; 7(1):8-11, 3. PubMed ID: 2954711
[No Abstract] [Full Text] [Related]
19. Molecular markers of hemostatic activation in atherosclerosis: a new concept in diagnostic profiling of endogenous pathophysiologic transition.
Fareed J; Walenga JM; Baker WH; Hayes A; Hoppensteadt DA
Semin Thromb Hemost; 1986 Apr; 12(2):102-9. PubMed ID: 2943019
[TBL] [Abstract][Full Text] [Related]
20. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease.
Fujinishi A; Takahara K; Ohba C; Nakashima Y; Kuroiwa A
Angiology; 1997 Jun; 48(6):515-21. PubMed ID: 9194537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
